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Orthopedic Treatment Outcomes in Class III Malocclusion
A Systematic Review
Laura De Toffola; Chiara Pavonia; Tiziano Baccettib; Lorenzo Franchib; Paola Cozzac
ABSTRACT
Objective: To assess the scientific evidence on the effectiveness of early orthopedic treatment
in Class III subjects.
Materials and Methods: A literature survey was performed by applying the Medline database
(Entrez PubMed). The survey covered the period from January 1966 to December 2005 and used
the Medical Subject Headings (MeSH). The following study types that reported data on the effects
of Class III treatment with orthopedic appliances (facial mask, chincup, FR-3) on intermaxillary
sagittal and vertical relationships were included: randomized clinical trials (RCTs), and prospective
and retrospective longitudinal controlled clinical trials (CCTs) with untreated Class III controls.
Results: The search strategy resulted in 536 articles. After selection according to criteria for
inclusion and exclusion, 19 articles qualified for the final review analysis. One RCT and 18 CCTs
were retrieved.
Conclusion: The quality standard of the retrieved investigations ranged from low (four studies)
to medium/high (five studies). Data derived from medium/high quality research described over
75% of success of orthopedic treatment of Class III malocclusion (RME and facial mask therapy)
at a follow-up observation 5 years after the end of orthopedic treatment.
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INTRODUCTION
Class III malocclusion is associated with a deviation
in the sagittal relationship of the maxilla and the man-
dible, characterized by a deficiency and/or a backward
position of the maxilla, or by prognathism and/or for-
ward position of the mandible.1 The incidence of this
malocclusion in the white population has been report-
ed to be 1% to 5%.2–4 In the Asian populations, how-
ever, the incidence ranges from 9% to 19%,5–7 and in
Latin populations the incidence is approximately 5%.8,9
The etiology of Class III malocclusion is multifactoral
a Research Fellow, Department of Orthodontics, University of
Rome ‘Tor Vergata’, Italy.
b Assistant Professor, Department of Orthodontics, University
of Florence; Thomas M. Graber Visiting Scholar, Department of
Orthodontics and Pediatric Dentistry, School of Dentistry, The
University of Michigan, Ann Arbor, Mich.
c Professor and Head, Department of Orthodontics, University
of Rome ‘Tor Vergata’, Italy.
Corresponding author: Tiziano Baccetti, DDS, PhD, Univer-
sita` degli Studi di Firenze, Via del Ponte di Mezzo, 46-48, 50127,
Firenze, Italy
(e-mail: t.baccetti@odonto.unifi.it)
Accepted: May 2007. Submitted: March 2007.
 2008 by The EH Angle Education and Research Foundation,
Inc.
because of an interaction of both hereditary and en-
vironmental factors. The contributions of the cranial
base, maxilla, mandible, and temporomandibular artic-
ulation have been described in detail in the litera-
ture.10–13 Class III malocclusions associated with cra-
niofacial disharmonies are much more difficult to treat
and tend to relapse.14–16
Early treatment of Class III malocclusion has been
advocated to reduce the need of treatment in the per-
manent dentition, when camouflage orthodontic treat-
ment or surgery become the only options.1 A series of
treatment approaches can be found in the literature
regarding orthopedic treatment in Class III malocclu-
sion.
The aim of the present study is to analyze the sci-
entific evidence on the actual outcomes of orthopedic
treatment in Class III malocclusion as derived from the
existing literature on peer-reviewed orthodontic jour-
nals according to the Cochrane collaboration princi-
ples. This systematic review was undertaken to an-
swer the following relevant questions:
• Is early orthopedic treatment of Class III malocclu-
sion effective?
• Which treatment modality is the most effective?
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Table 1. Search Strategy Results
MeSH Terms a Search Strategy Results
Malocclusion, Angle Class III 1066 articles
Malocclusion, Angle Class III and orthodontics, interceptive 77 articles
Malocclusion, Angle Class III and orthodontics, corrective 459 articles
a MeSH indicates Medical Subject Headings.
• Are treatment results stable at a posttreatment ob-
servation?
MATERIALS AND METHODS
Search Strategy
The strategy for performing this systematic review
was influenced mainly by the National Health Service
(NHS) Centre for Reviews and Dissemination.17 To
identify all the studies that examined the relationship
between early orthopedic treatment and Class III mal-
occlusion, a literature survey was done by applying the
Medline database (Entrez PubMed, www.ncbi.nim.
nih.gov). The survey covered the period from January
1966 to December 2005 and used the Medical Subject
Heading (MeSH) terms: ‘‘malocclusion and Angle
Class III,’’ which was crossed with MeSH terms ‘‘or-
thodontics, interceptive’’ and ‘‘orthodontics, corrective’’
(Table 1). In addition, a search in the Cochrane Con-
trolled Clinical Trials Register was performed.
Selection Criteria
The inclusion and exclusion criteria are given in de-
tail in Table 2. The following study types that reported
data on the treatment effects were included: meta-
analysis randomized clinical trials (RCTs) and pro-
spective and retrospective studies with concurrent un-
treated control groups (CCTs). The retrieved studies
had to use cephalometrics to analyze the effects of
orthopedic therapy on total mandibular length, total
maxillary length, and intermaxillary vertical and sagittal
relationship with respect to untreated Class III con-
trols. No restrictions were set for sample size. Labo-
ratory studies, descriptive studies, case reports, case
series, reviews, and opinion articles were excluded.
Data Collection and Analysis
According to the recommendations by Petre`n et al,18
data were collected on the following items: year of
publication, sample size, study design (meta-analysis,
RCT, CCT), treatment duration, observation time, suc-
cess rate, side effects, and authors’ conclusion. In ad-
dition, to document the methodological soundness of
each article, a quality evaluation modified from the
methods described by Antczak et al19 and Jadad et al20
was performed with respect to preestablished char-
acteristics. The following characteristics were used:
study design, posttreatment evaluation, sample size
and previous estimate of sample size, selection de-
scription, withdrawals (dropouts), method error analy-
sis, blinding in measurements, and adequacy of sta-
tistics. The following systematic scores were assigned
to individual retrieved articles:
• Adequacy of selection description: 2 points
• Study design (RCTs: 2 points, CCTs: 1 point)
• Posttreatment evaluation (No: 0 point; Yes: 2 points)
• Description of method error analysis (2 points)
• Adequacy of statistics (nonparametric tests used
when appropriate: 2 points; parametric tests used
when nonparametric tests would be more appropri-
ate: 1 point)
• Blinding in measurements (1 point).
The quality of the studies was considered as follows:
• Low: with a total score 5 points
• Medium: with a total score 5 and 7 points
• Medium/high: with a total score 7 and 9 points
• High: with a total score 10 points.
Two independent reviewers (LDT, CP) assessed the
articles separately. The data were extracted from each
article without blinding to the authors, and interexam-
iner conflicts were resolved by discussion of each ar-
ticle to reach a consensus. Two independent review-
ers performed the quality evaluation of the articles re-
trieved (LF and PC) with one author (TB) acting as the
coordinator.
RESULTS
The search strategy resulted in 536 articles. After
selection according to the inclusion/exclusion criteria
stated in Table 2, Table 3 articles qualified for the re-
view analysis.21–39 The main reasons for exclusion
were: case reports, reviews, opinion articles, studies
concerning treatment in permanent dentition/adult pa-
tients, and studies about association between Class III
malocclusion and malformation. Six of the studies
were performed in the United States,21,24,25,30,34,39 five in
Japan,28,29,31,33,37 four in Turkey,22,26,32,38 two in the
UK,23,27 one in Korea,35 and one in Italy.36
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Table 2. Inclusion and Exclusion Criteria for the Retrieved Studies
Inclusion Criteria Exclusion Criteria
Meta-analyses, randomized clinical trials (RCTs), prospective and
retrospective studies (CCTs)
Articles in English
Articles published from January 1966 to December 2006
Studies on growing patients
Studies conducted on lateral cephalograms including measure-
ments of total mandibular length, total maxillary length, intermax-
illary vertical and sagittal relationship
Untreated Class III control subjects
Case reports, case series, descriptive studies, review articles, opin-
ion articles, abstracts
Laboratory studies
Studies on adults
Studies about the association between Class III malocclusion and
craniofacial malformations
Epidemiologic studies
Studies on growth prediction
Studies concerning the comparison between different malocclusions
Studies about the association between Class III malocclusion and
TMJ diseases
Studies without an untreated control group or with a normal control
group
Studies on dental casts or without cephalometric analysis
Treatment combined with extractions
Surgically assisted treatment
Success of therapy as a criterion for case selection
Study Design and Treatment Modalities
The results of the review are summarized in Tables
3 and 4. No meta-analyses were found. The 19 articles
included one RCT39 and 18 retrospective CCTs.21–38
Three articles described the effects of chincup
alone27,29 or in association with fixed appliances.33 Sev-
en studies utilized a facemask alone23,24,26,28,32,38,39; four
articles described the orthopedic effect of a facemask
in association with rapid maxillary expanders,21,25,30,39
and one in combination with fixed appliances34; one
article described the effects of the facemask in com-
bination with a Bionator III.36 Two articles analyzed the
effects of the FR-3 appliance of Fra¨nkel,22,35 two of a
maxillary protractor bow appliance (MPBA),31,37 one of
double-plate appliance (DPA),38 and one utilized a
combination of an upper removable appliance in as-
sociation with an extraoral traction to the mandibular
dentition (EOT).23
Age of Groups
Treated Class III patients were 4 years 2 months28
to 12 years 4 months23 old, whereas the age range in
untreated groups was wider, as it varied from 4 years
2 months28 to 17 years 11 months.33
Treatment Duration and Class III Skeletal
Correction
Treatment duration varied between 5 years 2
months37 and 7 years 2 months,33 depending upon
treatment modalities. Twelve studies declared that
treatment was discontinued after the correction of
Class III malocclusion. Of these studies, six studies
interrupted active treatment after achieving a positive
overjet,24,26,27,28,31,37 one study after obtaining a Class I
molar relationship,32 and four after achieving both
goals.32,34,38,39
Success Rate
A 100% success rate was reported in five stud-
ies,21,26,32,33,35 85% in one study,28 and a 76% rate in
another study.34 The other articles did not declare the
success rate.
Correlation Between Gender and Treatment
Outcomes
Only three studies23,31,37 analyzed the influence of
gender on treatment outcomes. In two studies31,37 no
significant differences between genders were found,
suggesting that gender had little influence on treat-
ment effects. In one study23 values for each sex were
given separately, as statistically significant differences
were found, even if the composition of the groups with
regard to severity of malocclusion and age was more
difficult to manage. Three studies22,35,39 combined the
sexes because statistical significance was not found
between them.
Correlation Between Timing and Treatment
Outcomes
Only one study26 declared the skeletal age of sub-
jects at the beginning of treatment, but omitted the
method used to evaluate it. One study34 considered
only subjects that attained a skeletal maturity stag-
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Table 3. Summarized Data of the 19 Studies Included in the Review a
Article
Material and Age
Study
Design
Gender
Distribution
Treatment
Time
Observation
Time
Success
Rate
Side
Effects
Authors’
Conclusion
Ngan et al 199221 CCT Almost 100% Not declared Correction of Class III
primarily due to for-
ward and downward
movement of the
maxilla, downward
and backward rotation
of the mandible
10 RME  FM
(8.06y)
3M; 7F 6m
10 No treatment
(not declared)
10
Matched
6m
Ulgen and Firatli
199422
CCT Not declared Retrusion of lower
incisors
Increase ANB, decrease
SNB, retrusion lower
incisors
20 FR3 (9.5y) 10M; 10F 1.9y
20 No treatment
(9.3y)
10M; 10F 1.8y
Battagel and
Orton 199523
CCT Not declared Not declared Both therapies are ef-
fective. In FM group,
forward development
of the maxilla is seen
44 EOT  upper
removable ap-
pliance (12.4y)
27M; 17F 2.1y
39 FM (10.8y) 19M; 20F 2.0y
30 No treatment
(12.4y)
12M; 18F 3.0y
Chong et al 199624 CCT Not declared Retroclination of
mandibular incisors
Significant skeletal and
dentoalveolar changes
16 FM (6.8y 
1.13y)
8M; 8F 0.61y treat-
ment
1.66y
13 No treatment
(6.36y  0.54y)
8M; 5F 3.57y post
treatment
5.38y
Baccetti et al
199825
CCT Not declared Not declared Treatment in early
mixed dentition induc-
es more skeletal ad-
aptation than in late
mixed dentition
23 Early treated
RME  FM (6y
9m  7m)
20M; 26F 1y  5m
23 Late treated
RME  FM
(10y 3m  1 y)
10m  3m
17 Early untreated
(6y 5m  8m)
14M; 18F 1y 11m  1y
15 Late untreated
(9y 6m  1y)
1y 8m  10m
Kilic¸oglu and Kirlic¸
199826
CCT 16/16 Not declared Soft tissue facial angle
and facial convexity
decreased
16 FM (8.65y 
1.4y)
16F 0.99y 0.06y
10 No treatment
(9.29y  1.4y)
10F 1.03y  0.06y
Abu Alhaija and
Richardson
199927
CCT Not declared Proclination upper
incisors, retroclina-
tion lower incisors
Proclination upper inci-
sors, retroclination
lower incisors, redi-
rection mandibular
growth in a downward
direction
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Table 3. Continued
Article
Material and Age
Study
Design
Gender
Distribution
Treatment
Time
Observation
Time
Success
Rate
Side
Effects
Authors’
Conclusion
23 CC (8.11y 
0.96y)
14M; 9F 3.01y 
1.61y treat-
ment
23 No treatment
(not declared)
23 Matched 3.34y  1.8y
post treat-
ment
4.12y  1.86y
Deguchi et al
199928
CCT 85% Not declared Advancement of maxilla,
backward rotation of
mandible, correction
of anterior crossbite
40 FM (4y 2m) 40F 3y 3m treat-
ment
3y 3m
28 No treatment
(4y 2m)
28F 3y 7m post
retention
4y 1m
Deguchi and Mc-
Namara 199929
CCT Not declared Proclination upper
incisors; retroclina-
tion lower incisors
Reduction mandibular
growth increments
22 CC (9y 4m) 22F 1y 9m
20 No treatment
(9y 7m)
20F 30m
Baccetti et al
200030
CCT Not declared Not declared Treatment in early
mixed dentition induc-
es more skeletal ad-
aptation than in late
mixed dentition
16 RME  FM
(early treatment
group) (7y 
7m)
14M; 15F 10m  4m
early treat-
ment
1y 11m 
8m early
control1
13 RME  FM
(late treatment
group) (8y 8m
 1y)
1y 3m  7m
post treat-
ment
1y 9m 
10m late
control 1
17 Early untreated
control group1
(6y 5m  8m)
17 Matched
15 Late untreated
control group1
(9y 6m  1y
6m)
15 Matched 10m  2m
Late treat-
ment
1y 10m 
1y early
control 2
11 Early untreated
control group2
(7y 7m  7m)
11 Matched
10 Late untreated
control group2
(10y 3m  1y
5m)
10 Matched 1y 3m  7m
post treat-
ment
1y 9m 
10m late
control 2
Kajiyama et al
200031
CCT Not declared 70% skeletal move-
ment 30% incisor
movement (labial in-
clination of maxillary
incisors, lingual incli-
nation of mandibular
incisors)
Favorable changes in
craniofacial skeleton
and alveolus
29 MPBA (8y 7m
 1y 5m)
11M; 18F 10.2m  4.5m
25 No treatment
(8y 10m  1y
4m)
10M; 15F 8.4m  2.3m
Yuksel et al 200132 CCT 17/17 Significant forward
movement of upper
incisors
No significant difference
between the two
treated groups
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Table 3. Continued
Article
Material and Age
Study
Design
Gender
Distribution
Treatment
Time
Observation
Time
Success
Rate
Side
Effects
Authors’
Conclusion
17 Early FM (9y
8m)
11M; 6F 7m 17/17
17 Late FM (12y
6m)
9M; 8F 7m
17 No treatment
(9y 5m)
17 Matched 9m
Deguchi et al
200233
CCT 2y 7m short
term;
36/36 Long
term
Not declared Long-term therapy re-
sulted in an inhibition
of ramus height and
body length growth
than short-term therapy
20 CC force 500g
short term 
edgw (8y 4m)
20F 7y 2m long
term;
36 CC force
250g–300g long
term  edgw
(8y 4m)
36F 3y 3m reten-
tion short
term;
177 No treatment
(1302 no treat-
ment (8y) 3y
10m)
302F 5y 10m (T1–2)
83 No treatment
(17y 11m)
177F 4y 8m reten-
tion long
term
4y 1m (T2–3)
83F
Westwood et al
200334
CCT 10m  4m
(T1–2)
26/34 (76%) Retrusion of the lower
incisors in the first
phase of treatment
Significant response of
craniofacial skeleton
(forward movement of
the maxilla, downward
and backward move-
ment of the mandible)
34 RME  FM 
edgw (8y 3m 
1y 10m)
14M; 20F 5y 7m  2y
3m (T2–3)
12 Untreated T1–2
(8y 1m  2y
2m)
6M; 6F 1y 2m 
4m (T1–2)
15 Untreated T2–3
(8y 10m  2y
4m)
8M; 7F 6y  2y 2m
(T2–3)
22 Untreated T1–3
(8y 8m  2y
5m)
9M; 13F 6y 5m  2y
2m (T1–3)
Baik et al 200435 CCT Almost 100% Linguoversion of the
mandibular incisors
Backward and down-
ward rotation of man-
dible, linguoversion of
the mandibular inci-
sors
30 FR3 (8.0y 
1.2y)
13M; 17F 1.3y  0.6y
20 No treatment
(8.2y  1.1y)
10M; 10F 1.5y  0.6y
Cozza et al 200436 CCT Not declared Not declared Satisfactory correction
of class III by a signif-
icant maxillary for-
ward movement
30 FM  BIO3
(5.85y)
17M; 13F 1y 8m
24 No treatment
(5.97y)
14M; 10F 2y
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Table 3. Continued
Article
Material and Age
Study
Design
Gender
Distribution
Treatment
Time
Observation
Time
Success
Rate
Side
Effects
Authors’
Conclusion
Kajiyama et al
200437
CCT 5.2 m 
2.9m (de-
ciduous
dentition)
2 y 1m 
9.3m) (de-
ciduous
dentition
Not declared Labial inclination of
maxillary incisors in
the deciduous denti-
tion group might con-
tribute to a more rapid
correction of the ante-
rior crossbite
Greater forward dis-
placement of maxilla
and clockwise reloca-
tion of the mandible in
the deciduous denti-
tion group than in the
mixed dentition group
34 MPBA in de-
ciduous denti-
tion (5y 6m 
10m)
11M; 23F
29 MPBA in
mixed dentition
(8y 7m  1y
5m)
11M; 18F 8.4m 
2.3m
(mixed
dentition)
32 No treatment
in deciduous
dentition (4y 8m
 12m)
10M; 22F 10.2m  4.5m
(mixed den-
tition)
25 No treatment
in mixed denti-
tion (8y 10m 
1y 4m)
10M; 15F
Uc¸em et al 200438 CCT Not declared Significant protrusion of
maxillary incisors and
retrusion of mandibu-
lar incisors in the
DPA group
Sagittally, skeletal
changes were greater
in FM group.
14 DPA (10y 3m) 7M; 7F 9m
14 FM (10y 5m) 7M; 7F 9m
14 No treatment
(9y 8m)
8M; 6F 11m
Vaughn et al
200539
RCT Not declared Not declared Facemask therapy with
or without palatal ex-
pansion produced
equivalent changes in
the dentofacial com-
plex
15  6 RME 
FM (7.38y 
0.50y)
7M; 8F 1.16y
14  8 FM (8.10y
 0.52y)
7M; 7F 1.15y
17 No treatment
(6.62y  0.47y)
10M; 7F At least 12m
a CCT indicates controlled clinical trial; RCT, randomized clinical trial; RME, rapid maxillary expansion; FM, facemask; FR3, Fra¨nkel’s function
regulator FR-3; EOT, extraoral traction; CC, chincup; MPBA, maxillary protractor bow appliance; edgw, fixed appliance; BIO3, Bionator III;
DPA, double-plate appliance; y, years; m, months; F, female; M, male.
ing Cvs4, Cvs5, or Cvs6 at a long-term observation,
considering the developmental staging of the cervi-
cal vertebrae proposed by Franchi et al.40
Other studies25,27,28,30,31,35,37 considered the dental
stage at the beginning of treatment, varying from pri-
mary dentition,28,35,37 eruption stage of first molars and
incisors,25,27,30,35 completed eruption of molars and in-
cisors,31,37 and eruption stage of canines and/or pre-
molars.25,30
Treatment in deciduous dentition produces greater
skeletal changes than those produced in the mixed
dentition stage37; moreover, when therapy begins in
the early mixed dentition, it seems to induce more fa-
vorable changes in the craniofacial skeleton, com-
pared with the same treatment started in the late
mixed dentition.25,30
One study compared treatment outcomes in two dif-
ferent chronologic age groups32 without finding any
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Table 4. Quality Evaluation of the 19 Selected Studies a
Article
Sample Size
Material and
Age
Post-
treatment
Obser-
vation
Previous
estimate
of
Sample
Size
Selection
Description
Withdraw-
als
Method
Error
Analysis
Blinding
In
Measure-
ments
Statistics
Provided
Adequacy of
Statistics
Judged
Quality
Stan-
dard
Quality
Score
Ngan et al
199221
CCT No No Adequate No Yes No Yes t-Test 6 Medium
10 RME  FM
(8.06y)
10 No treat-
ment (not
declared)
Ulgen and Fir-
atli 199422
No No Adequate No Yes No Yes Wilcoxon rank test/
Mann-Whitney U-
test (nonparametric)
7 Medium
20 FR3 (9.5y)
20 No treat-
ment (9.3y)
Battagel and
Orton 199523
No No Adequate No Yes No Yes t-Test/Tukey’s HSD
(nonparametric)
7 Medium
44 EOT  up-
per remov-
able appli-
ance (12.4y)
39 FM (10.8y)
30 No treat-
ment (12.4y)
Chong et al
199624
Yes No Adequate No Yes No Yes t-Test/ Bonferroni cor-
rection & Wilcoxon
Ranked Sum test
(nonparametric)
9 Medium-high
16 FM (6.8y 
1.13y)
13 No treat-
ment (6.36y
 0.54y)
Baccetti et al
199825
No No Adequate No Yes No Yes Mann-Whitney U-test
(nonparametric)
7 Medium
23 RME  FM
(Early treat-
ment group)
23 Late treat-
ed RME 
FM (10y 3m
 1 y)
17 Early un-
treated (6y
5m  8m)
15 Late un-
treated (9y
6m  1y)
Kilic¸oglu and
Kirlic¸ 199826
No No Adequate No No No Yes t-Test 4 Low
16 FM (8.65y
 1.4y)
10 No treat-
ment (9.29y
 1.4y)
Abu Alhaija
and Rich-
ardson
199927
Yes No Adequate No Yes No Yes t-Test 8 Medium-high
23 CC (8.11y
 0.96y)
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Table 4. Continued
Article
Sample Size
Material and
Age
Post-
treatment
Obser-
vation
Previous
estimate
of
Sample
Size
Selection
Description
Withdraw-
als
Method
Error
Analysis
Blinding
In
Measure-
ments
Statistics
Provided
Adequacy of
Statistics
Judged
Quality
Stan-
dard
Quality
Score
23 No treat-
ment (not
declared)
Deguchi et al
199928
Yes No Adequate No No No Yes t-Test/F test 6 Medium
40 FM (4y 2m)
28 No treat-
ment (4y
2m)
Deguchi et al
199929
No No Adequate No No No Yes t-Test/F test 4 Low
22 CC (9y 4m)
20 No treat-
ment (9y
7m)
Baccetti et al
200030
Yes No Adequate No Yes No Yes Mann-Whitney U-test
(nonparametric)
9 Medium-high
16 RME  FM
(Early treat-
ment group)
(7y  7m)
13 RME  FM
(Late treat-
ment group)
(8y 8m 
1y)
17 Early un-
treated con-
trol group1
(6y 5m 
8m)
15 Late un-
treated con-
trol group1
(9y 6m  1y
6m)
11 Early un-
treated con-
trol group2
(7y 7m 
7m)
10 Late un-
treated con-
trol group2
(10y 3m 
1y 5m)
Kajiyama et al
200031
No No Adequate No No No Yes t-Test 4 Low
29 MPBA (8y
7m  1y
5m)
25 No treat-
ment (8y
10m  1y
4m)
Yuksel et al.
200132
No No Adequate No Yes No Yes Wilcoxon test/Mann-
Whitney U-test
(nonparametric)
7 Medium
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Table 4. Continued
Article
Sample Size
Material and
Age
Post-
treatment
Obser-
vation
Previous
estimate
of
Sample
Size
Selection
Description
Withdraw-
als
Method
Error
Analysis
Blinding
In
Measure-
ments
Statistics
Provided
Adequacy of
Statistics
Judged
Quality
Stan-
dard
Quality
Score
17 Early FM
(9y 8m)
17 Late FM
(12y 6m)
17 No treat-
ment (9y
5m)
Deguchi et al
200233
Yes No Adequate No No No Yes t-Test 6 Medium
20 CC force
500g short
term 
edgw (8y
4m)
36 CC force
250g–300g
long term 
edgw (8y
4m)
302 No treat-
ment (8y)
177 No treat-
ment (13y
10m)
83 No treat-
ment (17y
11m)
Westwood et
al 200334
Yes No Adequate No Yes No Yes Hotelling t2 test/statis-
tics
9 Medium-high
34 RME  FM
 edgw (8y
3m  1y
10m)
12 Untreated
T1–2 (8y 1m
 2y 2m)
15 Untreated
T2–3 (8y
10m  2y
4m)
22 Untreated
T1–3 (8y 8m
 2y 5m)
Baik et al
200435
No No Adequate No Yes No Yes 2 Sample t-test 6 Medium
30 FR3 (8.0y
 1.2y)
20 No treat-
ment (8.2y
 1.1y)
Cozza et al
200436
No No Adequate No Yes No Yes Friedman 2-way ANO-
VA & Wilcoxon
Ranked Sum test
Mann-Whitney U-
test (nonparametric)
7 Medium
30 FM  BIO3
(5.85y)
24 No treat-
ment (5.97y)
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Table 4. Continued
Article
Sample Size
Material and
Age
Post-
treatment
Obser-
vation
Previous
estimate
of
Sample
Size
Selection
Description
Withdraw-
als
Method
Error
Analysis
Blinding
In
Measure-
ments
Statistics
Provided
Adequacy of
Statistics
Judged
Quality
Stan-
dard
Quality
Score
Kajiyama et al
200437
CCT No No Adequate No No No Yes ANOVA/t-test 4 Low
34 MPBA in
deciduous
dentition (5y
6m  10m)
29 MPBA in
mixed denti-
tion (8y 7m
 1y 5m)
32 No treat-
ment in de-
ciduous
dentition (4y
8m  12m)
25 No treat-
ment in
mixed denti-
tion (8y 10m
 1y 4m)
Uc¸em et al
200438
No No Adequate No Yes No Yes Wilcoxon test/Duncan
test (nonparametric)
7 Medium
14 DPA (10y;
3m)
14 FM (10y
5m)
14 No treat-
ment (9y
8m)
Vaughn et al
200539
No No Adequate Yes (3) Yes Yes Yes t-Test 8 Medium-high
15  6 RME
 FM (7.38y
 0.50y)
14  8 FM
(8.10y 
0.52y)
17 No treat-
ment (6.62y
 0.47y)
a RME, rapid maxillary expansion; FM, facemask; FR3, Fra¨nkel’s function regulator FR-3; EOT, extraoral traction; CC, chincup; MPBA,
maxillary protractor bow appliance; edgw, fixed appliance; BIO3, Bionator III; DPA, double-plate appliance; y, years; m, months.
significant difference in the orthodontic and orthopedic
effects.
Side Effects
Ten articles* considered the modifications in the in-
clination of the upper and lower incisors as a dental
compensation during skeletal movement. In all these
articles a retrusion and linguoversion of the mandibu-
lar incisors, a protrusion and labioversion of the max-
* References 22, 24, 27, 29, 31, 32, 34, 35, 37, 38.
illary incisors, or a combination of these two dental
movements was found. Three articles did not report
changes in the inclination of the incisors.25,30,33 No
studies performed a cost-analysis.
Stability of Treatment Outcomes
Six studies gave information about the stability of
treatment,24,27,28,30,33,34 reporting cephalometric results
at a posttreatment observation.
One study30 included a later cephalometric obser-
vation at about 1 year from the end of active treatment.
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This study reported that relapse tendency in early
treatment subjects primarily affected the maxillary re-
gion, whereas late treatment subjects exhibited a sig-
nificant rebound in mandibular sagittal position.
Three studies included a cephalometric observation
about 3 years from the end of active orthopedic treat-
ment24,27,28: two of these24,28 reported a lack of signifi-
cant differences between treated and control groups,
suggesting that the favorable treatment effects on the
maxillomandibular relationship were maintained. How-
ever, the treatment effect of increased overjet was di-
minished, mainly due to proclination of the mandibular
incisors. Successfully treated cases demonstrated a
significantly greater change in overjet during treat-
ment, suggesting that some overcorrection may be
necessary for maintenance of a successful correction.
One study27 reported no statistically significant skeletal
or soft-tissue differences between the groups at the
end of posttreatment observation, except for the in-
creased overjet and overbite in the chincap subjects.
Two articles33,34 evaluated the posttreatment effects
of an initial phase of orthopedic treatment followed by
comprehensive edgewise therapy, with a follow-up ob-
servation at about 5 years from the end of orthopedic
treatment. Favorable skeletal change observed post
treatment was due almost entirely to the orthopedic
correction: during the posttreatment period, craniofa-
cial growth in treated subjects was similar to that of
untreated class III controls. Thus, aggressive overcor-
rection at a skeletal level appears to be advisable and
essential to the stability of the treatment outcome.34
Quality Analysis
Research quality was low in four studies,26,29,31,37 me-
dium in 10 studies,† and medium/high in five.24,27,30,34,39
The selection description was adequate in all studies.
Withdrawals (dropouts) were declared only in the RCT
study,39 and in this study the number of dropouts was
three. Nine articles used proper statistical meth-
ods22–24,25,30,32,34,36,38; in the remaining studies the choice
of a parametric test without data distribution analysis
was inadequate. Thirteen studies included a method
error analysis,‡ and only one article used blinding in
measurements.39 No study declared the presence of
ethical approval with regard to the employment of an
untreated control group with a Class III malocclusion.
No article declared a previous estimate of sample size.
DISCUSSION
In this systematic review, an exhaustive literature
search attempted to find all randomized and controlled
† References 21–23, 25, 28, 32, 33, 35, 36, 38.
‡ References 21–25, 27, 30, 32, 34, 35, 36, 38, 39.
clinical trials with concurrent untreated controls that
compared different treatment modalities for orthopedic
treatment in Class III malocclusion.
RCTs have been used rarely in orthodontics, and
this systematic review shows that only one RCT on
the outcomes of orthopedic Class III therapy was
found.39 In fact, several items required in quality re-
views are applicable scarcely in orthodontics (ie, pa-
tients blinded or observer blinded to treatment). An-
other reason can be defined as ‘‘ethical’’ or ‘‘logistic’’
because RCT patients are not able to choose treat-
ment, and some subjects may be designated to an
untreated control group (in which the treatment is post-
poned after the study period), and these subjects may
refuse to participate in the trial.
For these reasons both retrospective and prospec-
tive CCTs were included in this review. In most of the
studies, there were serious shortcomings, such as no
previous estimate of sample size, or no discussion on
the possibility of type II error occurring. Problems of
bias, lack of method error analysis, lack of blinding in
measurements, and deficient or lack of statistical
methods were other examples of drawbacks in most
of the studies. Withdrawals (dropouts) were well de-
clared in only one study.
The groups of Class III subjects analyzed in the ar-
ticles retrieved for this review were considered very
heterogenic with regard to age (especially in untreated
control groups), to treatment modality, and to treat-
ment duration. Cephalometric measurements per-
formed in the 19 studies were not comparable be-
cause different studies used different cephalometric
analyses (for instance, not all studies used ANB angle
to evaluate the skeletal sagittal relationship). More-
over, those studies that used the same cephalometric
analysis did not apply the same treatment timing, or
they did not show the same treatment duration, thus
rendering quantitative analysis of outcomes practically
impossible and clinically useless.
With regard to the quality standard of the retrieved
investigations, it ranged from low (four studies26,29,31,37)
to medium/high (five studies24,27,30,34,39). The only RCT39
analyzed a very specific aspect of orthopedic treat-
ment of Class III malocclusion (use of rapid maxillary
expansion [RME] in combination with a facial mask vs
no use of the RME), and the reported results were in
the short term. Therefore, even in the presence of data
derived from medium/high quality research34 that de-
scribed over 76% of success of orthopedic treatment
of Class III malocclusion (RME and facial mask ther-
apy) at a follow-up observation 5 years after the end
of orthopedic treatment, high quality investigations are
still needed to perform a definitive assessment of ef-
fectiveness of Class III treatment at the skeletal level.
An RCT on the effects of different orthopedic treatment
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modalities with a long-term observation at the end cra-
niofacial growth would be desirable.
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